Error loading player: No playable sources found

M105

A Curve Similarity Index for Testing Parallelism in Bioassay

Date
April 27, 2020
This product is not available for individual purchase, but it is available as part of the following products:

Potency determination via bioassay is a relative measure that requires an evaluation of parallelism between the dose-response relationships of a reference standard and sample material. Typical approaches for assessing parallelism include difference (p-value) and equivalence tests. These traditional methods rely on a statistical assessment of model parameters as opposed to direct evaluation of the similarity of the dose response curves. A simple and intuitive curve similarity approach is proposed that tests the hypothesis that the sample material is a dilution or concentration of the reference standard. The test is achieved by quantifying the total area between the two curves and provides a single composite measure of parallelism that ranges from 0 to 1. Both a frequentist and a Bayesian approach to the test are provided. A simulation study shows that the curve similarity approach overcomes the drawbacks of the typical methods and is effective at detecting parallelism and non-parallelism for bioassays.

Speaker

Speaker Image for Paul Faya
Eli Lilly & Company

Related Products

Thumbnail for Technical Aspects of Bioassays throughout the Product
Technical Aspects of Bioassays throughout the Product
The technical aspects of bioassay strategies are essential as ever while the biotech industry launches new biologics including modified proteins, DNA, RNA and cell-based therapeutics…
Thumbnail for Moroccan Good Regulatory Practices – Regulatory and Technical Requirements for the Registration of Medicines for Human Use in Morocco
Moroccan Good Regulatory Practices – Regulatory and Technical Requirements for the Registration of Medicines for Human Use in Morocco
Good Regulatory Practices are internationally recognised processes, systems, tools and methods for improving the quality of regulations. As specified by WHO, GRP aims at making sure that regulations are fit for purpose and will deliver what they are set out to achieve in terms of policy objectives…
Thumbnail for Bioassays for Bispecifics – Double the Trouble or Double the Fun?
Bioassays for Bispecifics – Double the Trouble or Double the Fun?
The structures and functions of modern biotherapeutics are becoming increasingly complex…